Continuus Pharmaceuticals Inc., Woburn, Massachusetts, has been awarded a $69,300,000 firm-fixed-price contract to develop a domestic production capability for critical active pharmaceutical ingredients and final dosage form medicines using their proprietary integrated continuous manufacturing technology.  These medicines are currently used to treat critically ill COVID-19 patients.  Work will be performed in Woburn, Massachusetts, and is expected to be completed April 15, 2023.  Fiscal 2021 other procurement funds in the full amount are being obligated at the time of award.  Air Force Life Cycle Management Center, Robins Air Force Base, Georgia, is the contracting activity (FA8505-20-S-0002).